The overexpression of P-glycoprotein (P-gp) in multidrug resistance (MDR) cancer cells increases the efflux of anticancer drugs thereby causing the failure of clinical chemotherapy. To address this obstacle, in this study, we rationally designed a near-infrared (NIR) light-responsive nitric oxide (NO) delivery nanoplatform for targeting the MDR tumors based on core-shell structured nanocomposites. The mesoporous silica shell provided abundant sites for modification of the NO donor, N-diazeniumdiolate, and tumor-targeting molecule, folic acid (FA), and enabled high encapsulation capacity for doxorubicin (DOX) loading. Under NIR light irradiation, the generation of NO gas can efficiently augment chemotherapeutic effects via the inhibition of P-gp expression. Simultaneously, the photothermal conversion agents of the Cu2-xSe core produce a large amount of heat for photothermal therapy (PTT). Finally, this combinational gas/chemo/PTT not only displays a superior and synergistic effect for overcoming MDR cancer, but also provides an efficient strategy to construct a multifunctional nano-drug delivery system with diversified therapeutic modalities.
Keyphrases
- cancer therapy
- multidrug resistant
- photodynamic therapy
- nitric oxide
- drug delivery
- drug release
- papillary thyroid
- drug resistant
- gram negative
- fluorescence imaging
- acinetobacter baumannii
- squamous cell
- klebsiella pneumoniae
- nitric oxide synthase
- fluorescent probe
- poor prognosis
- hydrogen peroxide
- room temperature
- squamous cell carcinoma
- lymph node metastasis
- locally advanced
- young adults